Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.
- DOI
- 10.1016/j.cllc.2026.06.001
- Published
- 2026 Jul
- Container
- Clinical lung cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cllc.2026.06.001,
title = {Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.},
author = {Shah R and Buchmeier EL and Kopp HG and Griesinger F and Reck M and Christoph DC and Kuon J and Frost N and Grohé C and Faehling M and Saalfeld FC and Hoffknecht P and Luan J and Roeper J and Chesi P and Kimmich M and Olchers T and Klotz LV and Chung I and Thomas M and Christopoulos P},
year = {2026},
journal = {Clinical lung cancer},
doi = {10.1016/j.cllc.2026.06.001},
url = {https://doi.org/10.1016/j.cllc.2026.06.001}
}RIS
TY - JOUR TI - Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study. AU - Shah R AU - Buchmeier EL AU - Kopp HG AU - Griesinger F AU - Reck M AU - Christoph DC AU - Kuon J AU - Frost N AU - Grohé C AU - Faehling M AU - Saalfeld FC AU - Hoffknecht P AU - Luan J AU - Roeper J AU - Chesi P AU - Kimmich M AU - Olchers T AU - Klotz LV AU - Chung I AU - Thomas M AU - Christopoulos P PY - 2026 JO - Clinical lung cancer DO - 10.1016/j.cllc.2026.06.001 UR - https://doi.org/10.1016/j.cllc.2026.06.001 ER -
APA
R, S., EL, B., HG, K., F, G., M, R., DC, C., J, K., N, F., C, G., M, F., FC, S., P, H., J, L., J, R., P, C., M, K., T, O., LV, K., I, C., M, T., & P, C. (2026). Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2026.06.001
Source records
- pubmed · retrieved 2026-09-25T17:06:10.463Z